Xinying Xue

1.7k total citations · 1 hit paper
54 papers, 1.0k citations indexed

About

Xinying Xue is a scholar working on Epidemiology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xinying Xue has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xinying Xue's work include Fungal Infections and Studies (18 papers), Antifungal resistance and susceptibility (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Xinying Xue is often cited by papers focused on Fungal Infections and Studies (18 papers), Antifungal resistance and susceptibility (15 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Xinying Xue collaborates with scholars based in China, United States and Germany. Xinying Xue's co-authors include Lei Pan, Sanhong Liu, Mingming Meng, Kaifei Wang, Xuefeng Zang, Chao Hu, Deqiang Kou, Ming Li, Jingdan Qiu and Yuxia Liu and has published in prestigious journals such as Nature Communications, Advanced Drug Delivery Reviews and Radiology.

In The Last Decade

Xinying Xue

52 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens

2024 43 citations Min Zhou, Longqiang Liu et al. Nature Microbiology profile →

Peers

Countries citing papers authored by Xinying Xue

Since Specialization

Citations

This map shows the geographic impact of Xinying Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinying Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinying Xue more than expected).

Fields of papers citing papers by Xinying Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinying Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinying Xue. The network helps show where Xinying Xue may publish in the future.

Co-authorship network of co-authors of Xinying Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Xinying Xue. A scholar is included among the top collaborators of Xinying Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinying Xue. Xinying Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLC 2025 ·Cancer Management and Research ·(unknown), Mei Xie, Jing Shen, (unknown), (unknown), (unknown), Xin Zhang, Yiran Liang, Yunsheng Yang, (unknown), Xiaolin Diao, (unknown), Hai Du, Xinying Xue, Jian‐Lin Wu	0
2	Latex microspheres lateral flow immunoassay with smartphone-based device for rapid detection of Cryptococcus 2024 ·Talanta ·Xuelei Zang, (unknown), (unknown), G. Shi, (unknown), (unknown), (unknown), (unknown), Lin Xie, Hui Deng, (unknown), (unknown), (unknown), Chao Song, Lidong Wu, Xinying Xue	7
3	The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD. 2024 ·BMC Cancer ·Mei Xie, Jie Gao, Xidong Ma, Jialin Song, Chongchong Wu, (unknown), (unknown), (unknown), (unknown), (unknown), Xin Zhang, Jie Yao, Ying Jing, (unknown), Jianxin Wang, Xinying Xue	4
4	A dual-targeting antifungal is effective against multidrug-resistant human fungal pathogens breakdown → 2024 ·Nature Microbiology ·Min Zhou, Longqiang Liu, Zihao Cong, Weinan Jiang, Ximian Xiao, Jiayang Xie, (unknown), Sheng Chen, Yueming Wu, Xinying Xue, Ning Shao, Runhui Liu	43
5	Rapid Cryptococcus electroporated-lysis and sensitive detection on a miniaturized platform 2024 ·Biosensors and Bioelectronics ·Xiangzhu Kong, (unknown), Zaizai Dong, (unknown), Xinying Xue, (unknown), Yusen Wang, (unknown), Xuelei Zang, Haisheng Qian, Lingqian Chang, Yang Wang	5
6	Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis 2024 ·International Immunopharmacology ·Xin Zhang, Jie Yao, Mei Xie, Yiran Liang, (unknown), Jialin Song, (unknown), Xidong Ma, Yuanyong Wang, Yinguang Zhang, (unknown), (unknown), (unknown), Xinying Xue	4
7	Confronting antifungal resistance, tolerance, and persistence: Advances in drug target discovery and delivery systems 2023 ·Advanced Drug Delivery Reviews ·Lei Chen, Lanyue Zhang, (unknown), Yi‐Ting Wang, Xiuyun Tian, Wenxia Fang, Xinying Xue, (unknown)	33
8	Virulence profiling of Cryptococcus gattii isolates in China: insights from a multi-center study 2023 ·Microbiology Spectrum ·Xuelei Zang, Weixin Ke, (unknown), (unknown), Jialin Song, (unknown), Meng Zhou, Qiqi Wang, (unknown), Bin Dai, (unknown), Dingxia Shen, Linqi Wang, Xinying Xue	2
9	Clinical characteristics and therapeutic effects of checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer 2023 ·BMC Cancer ·Li Pang, Mei Xie, Xidong Ma, (unknown), Jialin Song, Jie Yao, Hui Deng, Duchao Zhang, Xuelei Zang, (unknown), (unknown), Chongchong Wu, Yuanyong Wang, Xin Zhang, (unknown), Lei Pan, Xinying Xue	15
10	Characteristics and prognostic implications of peripheral blood lymphocyte subsets in patients with anti-MDA5 antibody positive dermatomyositis-interstitial lung disease 2023 ·BMC Pulmonary Medicine ·(unknown), Qi Chen, Shanshan Yao, (unknown), Xinying Xue, Weichao Zhao, Dong Wang, Zhiling Zhao, (unknown), Ting Li, Yawen Shen, Lan Gao, Xuelei Zang, Xinyu Bao, Zhaohui Tong	7
11	Combating increased antifungal drug resistance in <italic>Cryptococcus</italic>, what should we do in the future? 2023 ·Acta Biochimica et Biophysica Sinica ·(unknown), (unknown), (unknown), (unknown), Xuelei Zang, (unknown), Hongli Li, Bin Dai, Xinying Xue	4
12	Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment 2022 ·Frontiers in Immunology ·Yuanyong Wang, Guofang Lu, Xinying Xue, Mei Xie, Zhaoyang Wang, Zhiqiang Ma, Yingtong Feng, Changjian Shao, (unknown), Minghong Pan, (unknown), Xiaofei Li, Jing Han, Xiaolong Yan	19
13	PIWI-interacting RNAs in cancer: Biogenesis, function, and clinical significance 2022 ·Frontiers in Oncology ·Jie Yao, Mei Xie, Xidong Ma, Jialin Song, Yuanyong Wang, Xinying Xue	16
14	Atorvastatin attenuates surgery-induced BBB disruption and cognitive impairment partly by suppressing NF-κB pathway and NLRP3 inflammasome activation in aged mice 2021 ·Acta Biochimica et Biophysica Sinica ·Pengfei Liu, Quansheng Gao, Lei Guan, Yanting Hu, Jingwen Jiang, (unknown), (unknown), Xinying Xue, Hui Qiao, (unknown)	18
15	Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis 2021 ·BMC Cancer ·(unknown), (unknown), Xuelei Zang, Chongchong Wu, (unknown), Xiaoli Sun, Mei Xie, Xidong Ma, Hui Deng, Jialin Song, (unknown), Li Pang, Jin Qian, (unknown), (unknown), Yuanyuan Chen, Lei Pan, Guanglei Zhuang, Sanhong Liu, Xinying Xue	21
16	Clinical and microbiological characteristics of Cryptococcus gattii isolated from 7 hospitals in China 2020 ·BMC Microbiology ·Liang Jin, (unknown), Xinying Xue, Hua Wu, Lifeng Wang, Ling Guo, Dingxia Shen	10
17	Independent risk factors for lymph node metastasis in 2623 patients with Non–Small cell lung cancer 2020 ·Surgical Oncology ·Xinying Xue, Xuelei Zang, Yuxia Liu, Dongliang Lin, (unknown), Jie Gao, Chongchong Wu, Xidong Ma, Hui Deng, (unknown), Lei Pan, Zhiqiang Xue	8
18	Identifying an Eight-Gene Signature to Optimize Overall Survival Prediction of Esophageal Adenocarcinoma Using Bioinformatics Analysis of ceRNA Network 2020 ·OncoTargets and Therapy ·Yuanyong Wang, Naixin Liang, Zhiqiang Xue, Xinying Xue	8
19	Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer 2015 ·Journal of Cancer ·Jingdan Qiu, Xinying Xue, Chao Hu, (unknown), Deqiang Kou, (unknown), Ming Li	113
20	Gefitinib in combination with prednisolone to avoid interstitial lung disease during non-small cell lung cancer treatment: A case report 2013 ·Oncology Letters ·Xinying Xue, (unknown), Yuxia Liu, Lei Pan, Kaifei Wang, Lina Zhang, Na Wang, Bing Yang, Wang Jian-xin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact